Find participating medical centers and current study status in each of them

    Find participating medical centers

    Alectinib compared with chemotherapy in previously treated patients with ALK-positive NSCLC (ALUR)

    Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib

    • Cancer
    • Lung Cancer
    • Non-Small Cell Lung Cancer (NSCLC)